Skip to main content
Log in

The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol®) in human tumor cell lines

  • Original Articles
  • Paclitaxel Cremophor EL, Cell Cycle
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

We have perfomed DNA flow analysis, mitotic index studies, time-lapse photography, and paclitaxel uptake studies of human tumor cell lines exposed to paclitaxel. DNA flow analysis demonstrated that cells began accumulating in G2/M within 6 hrs of exposure to paclitaxel; by 12 hrs over 50% of cells accumulated in G2/M at all concentrations tested. After 24 hrs of exposure to 10 nM paclitaxel, cells underwent non-uniform mitotic division resulting in multinucleated cells. Of cells treated with 30 nM to 1000 nM paclitaxel, 75% to 85% remained blocked in G2/M for up to 72 hrs. Although a large proportion of cells treated with higher concentrations of paclitaxel (10,000 nM) was blocked in G2/M, a significant proportion (10% to 40%) of these cells was also in Gl. Cells exposed to lower concentrations of paclitaxel (10 nM to 1000 nM) in medium containing 0.135% (v/v) Cremophor EL also had a relatively large proportion in Gl. Mitotic index studies demonstrated that the paclitaxel-induced G2/M block was initially a mitotic block and that cells remained in mitosis for up to 24 hrs. With additional time of exposure to paclitaxel, mitotic index and time-lapse studies indicated that cells attempted to complete mitosis; however, cytokinesis was inhibited and cells became multinucleated. Time-lapse photography revealed that paclitaxel markedly prolonged the time in mitosis from 0.5 hr to 15 hr. High levels of Cremophor EL (0.135% v/v) markedly reduced the number of cells in mitosis but did not alter the mitotic delay induced by paclitaxel.3H-paclitaxel uptake studies revealed that high concentrations of Cremophor EL did reduce the rate of uptake of paclitaxel into cells but had little effect on total paclitaxel accumulation. These results confirm that paclitaxel has striking effects on the cell cycle and show that high concentrations of Cremophor EL are capable of inducing a cell cycle block distinct from the mitotic block seen with paclitaxel. These results also demonstrate that cells exposed to paclitaxel for longer than 24 hours attempt to complete mitosis but the process of cytokinesis is inhibited. Together with cytotoxicity data, these results indicate that entry into and exit out of mitosis are prerequisites for paclitaxel cytotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brenner SL, Brinkley BR (1982) Tubulin assembly sites and the organization of microtubule arrays in mammalian cells. Cold Spring Harbor Symp Quant Biol 46:241

    Google Scholar 

  2. Chaung LF, Israel M, Chuang RY (1991) Cremophor EL inhibits 12-O-tetradecanoylphorbol-13 acetate (TPA)-induced protein phosphorylation in human myeloblastic leukemia ML-1 cells. Anticancer Res 11:1517

    Google Scholar 

  3. Cook JA, DeGraff W, Teague D, Liebmann JE (1993) Radiation sensitization of Chinese hamster V79 cells by paclitaxel. Radiat Oncol Invest (in press)

  4. Cook JA, Liebmann J, Sullivan F, Hahn S, Teague D, DeGraff W, Mitchell JB (1993) Paclitaxel-mediated cytotoxicity in Chinese hamster V79 cells. Cancer Chemother Pharmacol (in press)

  5. Fox MH (1980) A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1:71

    Google Scholar 

  6. Hahn SM, Liebmann JE, Fisher J, Cook JA, Mitchell JB, Kaufman DK (1993) Paclitaxel in combination with doxorubicin and etoposide: possible antagonism in vitro. Cancer (in press)

  7. Liebmann JE, Hahn SM, Cook JA, Lipschultz CA, Mitchell JB, Kaufman DC (1993) Glutathione depletion byl-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res 53:2066

    Google Scholar 

  8. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB (1993) Cytotoxic studies of paclitaxel (Taxol®) in human tumor cell lines. Br J Cancer (in press)

  9. Lopes NM, Adams EG, Pitts TW, Bhuyan BK (1993) Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32:235

    Google Scholar 

  10. Manfredl JJ, Horwitz SB (1984) Taxol: an antimitotic agent with a unique mechanism of action. Pharmacol Ther 25:83

    Google Scholar 

  11. Markman M, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr, Rubin S, Curtin J, Barakat R, Phillips M, Hurowitz L, Almadrones L, Hoskins W (1992) Phase I trial of intraperitoneal taxol: a Gynecologic Oncology Group study. J Clin Oncol 10:1485

    Google Scholar 

  12. Rao S, Horwitz SB, Ringel I (1992) Direct photoaffinity labeling of tubulin with taxol. J Natl Cancer Inst 84:785

    Google Scholar 

  13. Rowinsky EK, Caenave LA, Donehower RC (1990) Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247

    Google Scholar 

  14. Schiff PB, Fant J, Auster LA, Horwitz SB (1978) Effects of taxol on cell growth and in vitro microtubule assembly. J Supramol Struct [Suppl] 2:328

    Google Scholar 

  15. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665

    Google Scholar 

  16. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent fromTaxus brevifolia. J Am Chem Soc 93:2325

    Google Scholar 

  17. Wiernik PH, Schwertz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E (1987) Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47:2486

    Google Scholar 

  18. Woodeock DM, Jefferson S, Linsenmeyer ME, Crowther PJ, Chojnowski GM, Williams B, Bertoncello I (1990) Reversal of the multidrug resistance phenotype with Cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res 50:4199

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liebmann, J., Cook, J.A., Lipschultz, C. et al. The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol®) in human tumor cell lines. Cancer Chemother. Pharmacol. 33, 331–339 (1994). https://doi.org/10.1007/BF00685909

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00685909

Keywords

Navigation